ALUVI Fundamental Analysis - UV GERMI SA

Fundamental Rating

Overall ALUVI gets a fundamental rating of 4 out of 10. We evaluated ALUVI against 109 industry peers in the Machinery industry. ALUVI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALUVI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALUVI was profitable.

Of the past 5 years ALUVI 4 years were profitable.

ALUVI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ALUVI has a Return On Assets of 5.27%. This is in the better half of the industry: ALUVI outperforms 67.89% of its industry peers.

Looking at the Return On Equity, with a value of 5.80%, ALUVI is in line with its industry, outperforming 44.95% of the companies in the same industry.

ALUVI has a Return On Invested Capital of 3.15%. This is in the lower half of the industry: ALUVI underperforms 69.72% of its industry peers.

		Industry Rank	Sector Rank
ROA	5.27%
ROE	5.8%
ROIC	3.15%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALUVI has a better Profit Margin (7.75%) than 76.15% of its industry peers.

ALUVI's Profit Margin has improved in the last couple of years.

ALUVI has a Operating Margin of 5.61%. This is comparable to the rest of the industry: ALUVI outperforms 45.87% of its industry peers.

ALUVI has a better Gross Margin (51.20%) than 66.97% of its industry peers.

ALUVI's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	5.61%
PM (TTM)	7.75%
GM	51.2%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y40.03%

GM growth 3Y3.79%

GM growth 5Y5.14%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALUVI has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALUVI has more shares outstanding

Compared to 1 year ago, ALUVI has an improved debt to assets ratio.

2.2 Solvency

ALUVI has an Altman-Z score of 6.25. This indicates that ALUVI is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of ALUVI (6.25) is better than 95.41% of its industry peers.

ALUVI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

ALUVI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. ALUVI outperforms 96.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	6.25

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

ALUVI has a Current Ratio of 7.88. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.

ALUVI has a Current ratio of 7.88. This is amongst the best in the industry. ALUVI outperforms 98.17% of its industry peers.

ALUVI has a Quick Ratio of 5.51. This indicates that ALUVI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 5.51, ALUVI belongs to the top of the industry, outperforming 98.17% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.88
Quick Ratio	5.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALUVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.00%, which is quite impressive.

ALUVI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.53% yearly.

Looking at the last year, ALUVI shows a decrease in Revenue. The Revenue has decreased by -9.66% in the last year.

Measured over the past years, ALUVI shows a small growth in Revenue. The Revenue has been growing by 6.64% on average per year.

EPS 1Y (TTM)200%

EPS 3YN/A

EPS 5Y42.53%

EPS Q2Q%-26.67%

Revenue 1Y (TTM)-9.66%

Revenue growth 3Y10.44%

Revenue growth 5Y6.64%

Sales Q2Q%-22.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALUVI is valuated correctly with a Price/Earnings ratio of 16.06.

75.23% of the companies in the same industry are more expensive than ALUVI, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 26.59, ALUVI is valued a bit cheaper.

		Industry Rank	Sector Rank
PE	16.06
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)0.38

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALUVI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

UV GERMI SA

EPA:ALUVI (12/10/2025, 7:00:00 PM)

2.89

-0.04 (-1.37%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)10-16 2025-10-16

Earnings (Next)N/A N/A

Inst Owners3.77%

Inst Owner ChangeN/A

Ins Owners26.64%

Ins Owner ChangeN/A

Market Cap9.33M

Revenue(TTM)7.48M

Net Income(TTM)580.00K

Analysts84.44

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	16.06
Fwd PE	N/A
P/S	1.25
P/FCF	N/A
P/OCF	N/A
P/B	0.96
P/tB	1.09
EV/EBITDA	N/A

EPS(TTM)0.18

EY6.23%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS2.32

BVpS3.02

TBVpS2.64

PEG (NY)N/A

PEG (5Y)0.38

Graham Number3.49

Profitability

		Industry Rank	Sector Rank
ROA	5.27%
ROE	5.8%
ROCE	4.29%
ROIC	3.15%
ROICexc	3.15%
ROICexgc	3.6%
OM	5.61%
PM (TTM)	7.75%
GM	51.2%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y40.03%

GM growth 3Y3.79%

GM growth 5Y5.14%

F-ScoreN/A

Asset Turnover0.68

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.88
Quick Ratio	5.51
Altman-Z	6.25

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)200%

EPS 3YN/A

EPS 5Y42.53%

EPS Q2Q%-26.67%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-9.66%

Revenue growth 3Y10.44%

Revenue growth 5Y6.64%

Sales Q2Q%-22.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y75%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

UV GERMI SA / ALUVI.PA FAQ

What is the fundamental rating for ALUVI stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALUVI.PA.

What is the valuation status for ALUVI stock?

ChartMill assigns a valuation rating of 1 / 10 to UV GERMI SA (ALUVI.PA). This can be considered as Overvalued.

What is the profitability of ALUVI stock?

UV GERMI SA (ALUVI.PA) has a profitability rating of 4 / 10.

What is the valuation of UV GERMI SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UV GERMI SA (ALUVI.PA) is 16.06 and the Price/Book (PB) ratio is 0.96.

UV GERMI SA (ALUVI.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

UV GERMI SA / ALUVI.PA FAQ

What is the fundamental rating for ALUVI stock?

What is the valuation status for ALUVI stock?

What is the profitability of ALUVI stock?

What is the valuation of UV GERMI SA based on its PE and PB ratios?